Thinking of joining a study?

Register your interest

NCT04834167 | Completed | Skin Diseases


OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women
Sponsor:

Tunku Abdul Rahman University

Information provided by (Responsible Party):

Yang Mooi Lim

Brief Summary:

OneDoc Picopulse™ is a radiopulse technology beauty grade device invented for treating melasma.

Condition or disease

Skin Diseases

Skin Disorder

Melanoma (Skin)

Intervention/treatment

OneDoc Picopulse

Phase

Not Applicable

Detailed Description:

This is a new attempt to evaluate the effectiveness of OneDoc PicopulseTM in treating melasma among women of childbearing age in Klang Valley, Malaysia. This pilot feasibility study protocol is to access feasibility of the OneDoc Picopulse™ in the future definitive trial. The findings of this study would justify OneDoc Picopulse™ as one of the promising alternative treatment for melasma.}}

Study Type : Interventional
Estimated Enrollment : 32 participants
Masking : None (Open Label)
Primary Purpose : Treatment
Official Title : OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women
Actual Study Start Date : May 1, 2021
Estimated Primary Completion Date : December 1, 2022
Estimated Study Completion Date : December 1, 2022
Arm Intervention/treatment

Experimental: Treatment

Eligible patients will receive ten picopulse treatments for bi-monthly.

Device: OneDoc Picopulse

Ages Eligible for Study: 18 Years to 65 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Women presenting dermal melasma with Fritzpatrick skin type III to V
  • Malaysian citizen
  • Agreed to participate
  • Provide informed consent
Exclusion Criteria
  • Patients who had a laser procedure, phototherapy therapy, peel, oral therapy, topical treatment or used lightening creams in the treatment area within the past 6 months.
  • Patients with pregnancy, lactating, active dermatitis, had a history of immunosuppression/immune deficiency disorders
  • Patients who photosensitivity or taking drugs known to induce photosensitivity,
  • Patients that have been exposed to severe sun exposure, having severe epidermal injury, allergy and sensitivity
  • Patients who could not attend follow-up treatments

OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women

Location Details


Please Choose a site



OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Malaysia,

OneDoc

Sharp, Malaysia,

Loading...